Results 11 to 20 of about 681,830 (299)

Antifungal susceptibility profiles of 1698 yeast reference strains revealing potential emerging human pathogens. [PDF]

PLoS ONE, 2012
New molecular identification techniques and the increased number of patients with various immune defects or underlying conditions lead to the emergence and/or the description of novel species of human and animal fungal opportunistic pathogens. Antifungal
Marie Desnos-Ollivier, Vincent Robert, Dorothée Raoux-Barbot, Marizeth Groenewald, Françoise Dromer   +4 more
doaj   +2 more sources

Species distribution and in vitro antifungal susceptibility of oral yeast isolates from Tanzanian HIV-infected patients with primary and recurrent oropharyngeal candidiasis [PDF]

BMC Microbiology, 2008
Background In Tanzania, little is known on the species distribution and antifungal susceptibility profiles of yeast isolates from HIV-infected patients with primary and recurrent oropharyngeal candidiasis. Methods A total of 296 clinical oral yeasts were
Rijs Antonius JMM, Helderman Wim, Mikx Frans HM, Mugusi Ferdinand, Simon Elison NM, Moshi Mainen J, Matee Mecky IN, Hamza Omar JM, van der Ven André JAM, Verweij Paul E   +9 more
doaj   +3 more sources

A Practical Guide to Antifungal Susceptibility Testing

Journal of the Pediatric Infectious Diseases Society, 2023
We review antifungal susceptibility testing and the development of clinical breakpoints, and detail an approach to using antifungal susceptibility results when breakpoints have not been defined. This information may prove helpful when selecting therapy for invasive fungal infections in children.
William R Otto, Maiken Cavling Arendrup, Brian T Fisher   +2 more
openaire   +4 more sources

Standardization of antifungal susceptibility testing [PDF]

Journal of Antimicrobial Chemotherapy, 1996
The application of in-vitro antifungal susceptibility testing to clinical research and to the guidance of antifungal therapy has been limited by a lack of reproducibility and uncertain clinical relevance. As a result of studies of the identified variables impacting on in-vitro susceptibility results, the National Committee for Clinical Laboratory ...
M G, Cormican, M A, Pfaller
openaire   +3 more sources

Multicentric Analysis of the Species Distribution and Antifungal Susceptibility of Clinical Isolates from Aspergillus Section Circumdati

, 2023
The clinical involvement and antifungal susceptibility of Aspergillus section Circumdati are poorly known. We analyzed 52 isolates, including 48 clinical isolates, belonging to 9 species inside the section Circumdati.
R. Piarroux, S. Imbert, L. Hasseine, P. Becker, S. Brun, C. Mahinc, F. Gabriel, A. Fekkar, D. Costa, S. Cassaing, A.C. Normand, C. Schuttler, L. Lachaud, C. Bonnal, M. Demar, A. Moreno-Sabater   +15 more
core   +1 more source

Autophagy Alters the Susceptibility of Candida albicans Biofilms to Antifungal Agents

Microorganisms, 2023
Candida albicans (C. albicans) reigns as a major cause of clinical candidiasis. C. albicans biofilms are known to increase resistance to antifungal agents, making biofilm-related infections particularly challenging to treat.
Jiadi Shen, Ming Ma, Wei Duan, Yun Huang, Banruo Shi, Qiaochu Wu, Xin Wei   +6 more
doaj   +1 more source

Antifungal susceptibility testing for yeasts: how, when and why, according to the new EUCAST guidelines

Microbiologia Medica, 2011
Antifungal susceptibility testing of yeasts and the development of interpretive breakpoints are nowadays very important topics both for the increasing incidence of invasive mycoses and number of available antifungal drugs and for the appearance of ...
Esther Manso, Claudio Farina, Stefano Andreoni, Marco Conte, Paolo Fazii, Gianluigi Lombardi, Silvana Sanna   +6 more
doaj   +1 more source

Fluconazole Resistance and Heteroresistance in Cryptococcus spp.: Mechanisms and Implications [PDF]

Revista da Sociedade Brasileira de Medicina Tropical
The reference methodology for evaluating antifungal susceptibility is based on determining the minimum inhibitory concentration (MIC), which is the lowest drug concentration capable of inhibiting fungal growth.
Izabela de Mesquita Bárcia Moreira, Naira Sulany Oliveira de Sousa, Juan Diego Ribeiro de Almeida, Robert Langlady Lira Rosas Filho, Katia Santana Cruz, Ani Beatriz Jackisch Matsuura, Márcia de Souza Carvalho Melhem, Érica Simplício de Souza, Hagen Frickmann, Marcus Vinícius Guimarães Lacerda, João Vicente Braga de Souza   +10 more
doaj   +1 more source

Phase-Dependent Differential In Vitro and Ex Vivo Susceptibility of Aspergillus flavus and Fusarium keratoplasticum to Azole Antifungals

Journal of Fungi, 2023
Fungal keratitis (FK) is an invasive infection of the cornea primarily associated with Aspergillus and Fusarium species. FK is treated empirically with a limited selection of topical antifungals with varying levels of success.
Darby Roberts, Jacklyn Salmon, Marc A. Cubeta, Brian C. Gilger   +3 more
doaj   +1 more source

Evaluation of antifungal susceptibility testing in Candida isolates by Candifast and disk-diffusion method

Indian Journal of Pathology and Microbiology, 2014
With the increase in invasive fungal infections due to Candida species and resistance to antifungal therapy, in vitro antifungal susceptibility testing is becoming an important part of clinical microbiology laboratories.
Sidhartha Giri, Anupma Jyoti Kindo
doaj   +1 more source